MicroRNA Regulation of Oncolytic Herpes Simplex Virus-1 for Selective Killing of Prostate Cancer Cells
Authors:
Open Access
- 12 August 2009
- journal article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 15 (16) , 5126-5135
Abstract
Purpose: Advanced castration-resistant prostate cancer, for which there are few treatment options, remains one of the leading causes of cancer death. MicroRNAs (miRNA) have provided a new opportunity for more stringent regulation of tumor-specific viral replication. The purpose of this study was to provide a proof-of-principle that miRNA-regulated oncolytic herpes simplex virus-1 (HSV-1) virus can selectively target cancer cells with reduced toxicity to normal tissues.Keywords
This publication has 48 references indexed in Scilit:
- Cancer Statistics, 2008CA: A Cancer Journal for Clinicians, 2008
- Widespread deregulation of microRNA expression in human prostate cancerOncogene, 2007
- Altered Expression of miR-21, miR-31, miR-143 and miR-145 Is Related to Clinicopathologic Features of Colorectal CancerOncology, 2007
- Oncomirs — microRNAs with a role in cancerNature Reviews Cancer, 2006
- MicroRNA Gene Expression Deregulation in Human Breast CancerCancer Research, 2005
- MicroRNA expression profiles classify human cancersNature, 2005
- The functions of animal microRNAsNature, 2004
- Oncolytic herpes simplex virus vectors for cancer virotherapyCancer Gene Therapy, 2002
- Regulation of Herpes Simplex Virus 1 Replication Using Tumor-Associated PromotersAnnals of Surgery, 2002
- A cancer gene therapy approach through translational control of a suicide geneCancer Gene Therapy, 2002